150 related articles for article (PubMed ID: 1370668)
21. Complement regulatory molecules on human myelin and glial cells: differential expression affects the deposition of activated complement proteins.
Koski CL; Estep AE; Sawant-Mane S; Shin ML; Highbarger L; Hansch GM
J Neurochem; 1996 Jan; 66(1):303-12. PubMed ID: 8522968
[TBL] [Abstract][Full Text] [Related]
22. Spontaneous classical pathway activation and deficiency of membrane regulators render human neurons susceptible to complement lysis.
Singhrao SK; Neal JW; Rushmere NK; Morgan BP; Gasque P
Am J Pathol; 2000 Sep; 157(3):905-18. PubMed ID: 10980130
[TBL] [Abstract][Full Text] [Related]
23. Engineering of recombinant soluble CD46: an inhibitor of complement activation.
Christiansen D; Milland J; Thorley BR; McKenzie IF; Mottram PL; Purcell LJ; Loveland BE
Immunology; 1996 Mar; 87(3):348-54. PubMed ID: 8778018
[TBL] [Abstract][Full Text] [Related]
24. Measles virus and C3 binding sites are distinct on membrane cofactor protein (CD46).
Manchester M; Valsamakis A; Kaufman R; Liszewski MK; Alvarez J; Atkinson JP; Lublin DM; Oldstone MB
Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2303-7. PubMed ID: 7534417
[TBL] [Abstract][Full Text] [Related]
25. Cytokines affect resistance of human renal tumour cells to complement-mediated injury.
Blok VT; Gelderman KA; Tijsma OH; Daha MR; Gorter A
Scand J Immunol; 2003 Jun; 57(6):591-9. PubMed ID: 12791098
[TBL] [Abstract][Full Text] [Related]
26. A soluble chimeric complement inhibitory protein that possesses both decay-accelerating and factor I cofactor activities.
Higgins PJ; Ko JL; Lobell R; Sardonini C; Alessi MK; Yeh CG
J Immunol; 1997 Mar; 158(6):2872-81. PubMed ID: 9058824
[TBL] [Abstract][Full Text] [Related]
27. Reoxygenation of hypoxic human umbilical vein endothelial cells activates the classic complement pathway.
Collard CD; Väkevä A; Büküsoglu C; Zünd G; Sperati CJ; Colgan SP; Stahl GL
Circulation; 1997 Jul; 96(1):326-33. PubMed ID: 9236453
[TBL] [Abstract][Full Text] [Related]
28. Expression of complement regulatory proteins on islets of Langerhans: a comparison between human islets and islets isolated from normal and hDAF transgenic pigs.
Bennet W; Björkland A; Sundberg B; Brandhorst D; Brendel MD; Richards A; White DJ; Nilsson B; Groth CG; Korsgren O
Transplantation; 2001 Jul; 72(2):312-9. PubMed ID: 11477359
[TBL] [Abstract][Full Text] [Related]
29. Expression of CD59, a regulator of the membrane attack complex of complement, on human astrocytes.
Gordon DL; Sadlon T; Hefford C; Adrian D
Brain Res Mol Brain Res; 1993 Jun; 18(4):335-8. PubMed ID: 7686996
[TBL] [Abstract][Full Text] [Related]
30. CD46 (membrane cofactor protein of complement, measles virus receptor): structural and functional divergence among species (review).
Seya T; Nomura M; Murakami Y; Begum NA; Matsumoto M; Nagasawa S
Int J Mol Med; 1998 May; 1(5):809-16. PubMed ID: 9852300
[TBL] [Abstract][Full Text] [Related]
31. Levels of cell membrane CD59 regulate the extent of complement-mediated lysis of human melanoma cells.
Brasoveanu LI; Altomonte M; Fonsatti E; Colizzi F; Coral S; Nicotra MR; Cattarossi I; Cattelan A; Natali PG; Maio M
Lab Invest; 1996 Jan; 74(1):33-42. PubMed ID: 8569195
[TBL] [Abstract][Full Text] [Related]
32. Adenovirus-mediated triple gene transfer of human complement regulating proteins to the porcine endothelial cell.
Nagahama M; Shiraishi M; Oshiro T; Muto Y
Transplant Proc; 2000 Nov; 32(7):2511-3. PubMed ID: 11120272
[No Abstract] [Full Text] [Related]
33. CRISPR/Cas9 generated human CD46, CD55 and CD59 knockout cell lines as a tool for complement research.
Thielen AJF; van Baarsen IM; Jongsma ML; Zeerleder S; Spaapen RM; Wouters D
J Immunol Methods; 2018 May; 456():15-22. PubMed ID: 29447841
[TBL] [Abstract][Full Text] [Related]
34. Expression of CD46, CD55, and CD59 on renal tumor cell lines and their role in preventing complement-mediated tumor cell lysis.
Gorter A; Blok VT; Haasnoot WH; Ensink NG; Daha MR; Fleuren GJ
Lab Invest; 1996 Jun; 74(6):1039-49. PubMed ID: 8667608
[TBL] [Abstract][Full Text] [Related]
35. Subtractive expression cloning reveals high expression of CD46 at the blood-brain barrier.
Shusta EV; Zhu C; Boado RJ; Pardridge WM
J Neuropathol Exp Neurol; 2002 Jul; 61(7):597-604. PubMed ID: 12125738
[TBL] [Abstract][Full Text] [Related]
36. Identification of four different CD46 (MCP) molecules with anti-peptide antibodies.
Purcell DF; Jonstone RW; McKenzie IF
Biochem Biophys Res Commun; 1991 Oct; 180(2):1091-7. PubMed ID: 1953714
[TBL] [Abstract][Full Text] [Related]
37. Molecular cloning of a pig homologue of membrane cofactor protein (CD46).
Toyomura K; Fujimura T; Murakami H; Natsume T; Shigehisa T; Inoue N; Takeda J; Kinoshita T
Int Immunol; 1997 Jun; 9(6):869-76. PubMed ID: 9199970
[TBL] [Abstract][Full Text] [Related]
38. Complement components, but not complement inhibitors, are upregulated in atherosclerotic plaques.
Yasojima K; Schwab C; McGeer EG; McGeer PL
Arterioscler Thromb Vasc Biol; 2001 Jul; 21(7):1214-9. PubMed ID: 11451754
[TBL] [Abstract][Full Text] [Related]
39. Distribution of complement regulators (CD46, CD55 and CD59) in skin appendages, and in benign and malignant skin neoplasms.
Sayama K; Shiraishi S; Miki Y
Br J Dermatol; 1992 Jul; 127(1):1-4. PubMed ID: 1379063
[TBL] [Abstract][Full Text] [Related]
40. Three soluble form messages of murine CD46 are produced through alternative mRNA splicing.
Tsujimura A; Nunoue K; Inoue N; Shida K; Kurita-Taniguchi M; Matsumoto M; Nomura M; Takeya T; Seya T
J Biochem; 2001 Dec; 130(6):841-8. PubMed ID: 11726285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
